Company Overview
GreenPeptide Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing novel cancer immunotherapeutics. Our pipeline includes not only cancer peptide vaccine but rejuvenated T cell therapy and immuno-modulator antibodies. Our basic business model covers research and early clinical development, followed by out-licensing to pharmaceutical companies. We also search for in-licensing and/or research collaboration opportunities in I/O field.